利多卡因通过阻断致病性CGRP信号介导的感觉神经元与树突状细胞通讯改善银屑病
该研究通过硬膜外注射利多卡因治疗银屑病患者的小型先导试验,发现利多卡因可显著降低患者临床评分,并在咪喹莫特诱导的大鼠模型中改善银屑病,效果与全身给予TNF-α抗体相当;机制上,利多卡因抑制皮肤神经异常生长和背根神经节神经元过量产生降钙素基因相关肽(CGRP),并通过干扰CGRP信号抑制树突状细胞与背根神经节神经元共培养时的IL-23产生。单细胞RNA测序显示银屑病患者真皮树突状细胞群中CGRP受体过度表达。结论认为硬膜外利多卡因神经阻滞是银屑病的有效疗法。
要点
- 硬膜外注射利多卡因可显著降低银屑病患者临床评分。
- 利多卡因改善咪喹莫特诱导大鼠银屑病模型,效果与全身TNF-α抗体相当。
- 利多卡因通过干扰CGRP信号抑制银屑病树突状细胞产生IL-23。
核心结论
- 硬膜外利多卡因神经阻滞是银屑病的有效疗法,可抑制炎症皮肤中感觉神经异常生长及CGRP介导的银屑病树突状细胞IL-23产生。
研究设计与样本
- 先导研究,使用硬膜外注射利多卡因治疗银屑病患者,并辅以咪喹莫特诱导的大鼠银屑病模型及单细胞RNA测序。
主要发现
- 利多卡因治疗显著降低患者临床评分。
- 利多卡因改善咪喹莫特诱导大鼠银屑病模型,效果与全身给予TNF-α抗体相当。
- 咪喹莫特诱导皮肤神经异常生长及背根神经节神经元过量产生CGRP,两者均被硬膜外利多卡因抑制。
- 单细胞RNA测序显示银屑病患者真皮树突状细胞群中CGRP受体过度表达。
- 利多卡因通过干扰CGRP信号抑制与背根神经节神经元共培养的树突状细胞产生IL-23。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic immune-mediated skin disorder with the nervous system contributing to its pathology. The neurogenic mediators of psoriasis are elusive, and whether the intervention of the cutaneous nervous system can treat psoriasis remains to be determined. In this study, we conducted a pilot study using an epidural injection of lidocaine to treat patients with psoriasis. Lidocaine treatment markedly reduced patients' clinical scores and improved an imiquimod-induced rat model of psoriasis as competent as systemic delivery of a TNF-α antibody. Imiquimod application elicited aberrant cutaneous nerve outgrowth and excessive generation of neuropeptide calcitonin gene-related peptide from dorsal root ganglion neurons, both of which were inhibited by epidural lidocaine treatment. Single-cell RNA sequencing unveiled the overrepresentation of calcitonin gene-related peptide receptors in dermal dendritic cell populations of patients with psoriasis. Through disturbing calcitonin gene-related peptide signaling, lidocaine inhibited IL-23 production by dendritic cells cocultured with dorsal root ganglion neurons. Thus, epidural nerve block with lidocaine demonstrates an effective therapy for psoriasis, which suppresses both inordinate sensory nerve growth in the inflamed skin and calcitonin gene-related peptide-mediated IL-23 production from psoriatic dendritic cells.
引用
- Yin Q, Sun L, Cai X, et al. Lidocaine Ameliorates Psoriasis by Obstructing Pathogenic CGRP Signaling‒Mediated Sensory Neuron‒Dendritic Cell Communication. J Invest Dermatol. 2022. PMID: 35032503. doi:10.1016/j.jid.2022.01.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。